Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2401 - 2408 of 11533 results
Journeys to Equity: Jennifer Rubin on Leadership and Accountability
September 7, 2021| Podcast| Viewpoint
Proposed Laws Are One Step Closer to the November 2022 Ballot
September 3, 2021| Blog| Viewpoint
US Open for FRAND Business: The Fifth Circuit Vindicates Ericsson, Finding that Ericsson’s Offers were FRAND
September 3, 2021| Blog| Viewpoint
Patent Owner Tip #17 for Surviving an Instituted IPR: Alternatives to Motions to Amend in IPR Proceedings
September 2, 2021| Blog| Viewpoint
FBI Warning: Ransomware Attackers Don’t Take Holidays
September 2, 2021| Blog| Viewpoint
How to Handle Religious Objections to a Workplace Vaccine Mandate
September 2, 2021| Blog| Viewpoint
Life Sciences Newsletter — September 2021
September 1, 2021| Article| Viewpoint
Immigration Lawyers Reveal 8 Secret Behind Their Strategies to Win Visas for Startup Workers
September 1, 2021| News
News & Press Releases
Mintz Advises Aspen Aerogels on $98M Follow-on Offering
November 19, 2024
Mintz advised Aspen Aerogels, Inc. (NYSE: ASPN), a technology leader in sustainability and electrification solutions, on a registered follow-on offering of 4,887,500 shares of its common stock, which included 637,500 shares pursuant to the underwriters’ option to purchase additional shares of its common stock. The price to the public in the offering was $20.00 per share and the gross proceeds to Aspen from the offering were approximately $98 million, before deducting underwriting discounts and commissions and estimated offering expenses.
Mintz Recovers Over $400M for Institutional Investor Clients in 2024
November 14, 2024
Mintz's Institutional Investor Class Action Recovery Practice has recovered $400 million for institutional investor clients in 2024 and expects projects for recoveries exceeding $500 million by year end.
Structuring Your Company for Cross-Border Opportunities in Life Sciences
November 14, 2024
An article written by International Life Sciences Chair Cheryl Reicin and Associate Luke Jeagal was published in BIOTECanada's Insights Magazine focusing on how life sciences companies should structure themselves so that they have cross-border opportunities.
Events
Podcasts
Health Law Diagnosed – Women Leaders in Health Care: Investing in Women’s Health
October 11, 2024| Podcast|
Health Law Diagnosed – Women Leaders in Health Care: The Emerging Role of AI in Health Care
March 22, 2024| Podcast|